Student Work

Development and Analysis of a Novel Nanotherapeutic for the Treatment of Multi-drug Resistant Ovarian Cancer

Public

Downloadable Content

open in viewer

Ovarian cancer, when treated with platinum and taxanes, is frequently detected in later stages and often develops multi-drug resistant properties. Therefore, chemotherapy regiments can become ineffective, leaving clinicians with less efficacious therapies. Our hypothesis is that a nanotherapy approach, utilizing nanoemulsions (NE) to deliver a combination of drugs with synergistic mechanisms of action, will likely reduce the spread of ovarian cancer and deliver the combination with reduced systemic toxicity. Results suggest that combination NEs can be manufactured and show some promise to kill ovarian cancer cells more efficiently.

  • This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.
Creator
Publisher
Identifier
  • E-project-043015-120438
Advisor
Year
  • 2015
Sponsor
Date created
  • 2015-04-30
Resource type
Major
Rights statement
Last modified
  • 2021-01-29

Relations

In Collection:

Items

Items

Permanent link to this page: https://digital.wpi.edu/show/sn00b0608